Hwasun Jeonnam National University Hospital Establishes 'Specimen Testing Automation System'

Cutting-Edge System with Processing Speed Over Twice as Fast

[Asia Economy Honam Reporting Headquarters Reporter Yoon Jamin] Hwasun Chonnam National University Hospital (Director Shin Myung-geun), which introduced the specimen test automation system for the first time in the Honam region in 2004, has dramatically improved its system by upgrading to a cutting-edge system that processes more than twice as fast as before.

Hwasun Chonnam National University Hospital announced on the 2nd that it recently established and officially started operating the specimen test automation system called ‘Hitachi TLA System Labospect TS (hereinafter TLA system).’

The TLA system is a state-of-the-art system that automates the entire process from transporting, analyzing, to producing results of blood specimens collected from patients.

The time required to obtain test results from patient specimens during laboratory operation has been reduced to about one-fourth compared to the previous system.

It also eliminated various errors that could occur when manually handling collected specimens and the risk of infection exposure to laboratory personnel from the specimens.

The newly introduced TLA system processes more than twice as fast as the previous one, and with features such as refrigerated centrifugation and RFID (Radio Frequency Identification) specimen movement applied, it can provide faster and more accurate test results, greatly enhancing the quality of medical services.

In particular, the immunology analyzer ‘Abbott Alinity 3M’ is the first case in Korea where three modules are connected to an automated system, demonstrating the excellence and compatibility of the TLA system.

Park Joo-heon, head of the Department of Laboratory Medicine, said, “The newly established TLA system will serve as a foothold to firmly establish Hwasun Chonnam National University Hospital’s position as a world-leading cancer specialty hospital by providing the best medical services to patients beyond Korea.”

This content was produced with the assistance of AI translation services.